期刊文献+

福建省HIV感染者/AIDS患者生存时间及影响因素分析 被引量:8

Analysis on the survival time and related factors among HIV/AIDS patients in Fujian province
原文传递
导出
摘要 目的探讨福建省HIV感染者/AIDS患者(HIV/AIDS患者)生存时间及影响因素。方法选择1987年1月1日至2014年12月31日福建省新报告的HIV/AIDS患者进入研究队列,收集HIV/AIDS患者全死因死亡相关信息,计算HIV/AIDS患者的全死因死亡率和生存率,应用单因素和多因素分析法探讨HIV/AIDS患者生存时间的影响因素。结果 1987-2014年福建省共有HIV/AIDS患者5 163例纳入研究,报告死亡849例,全死因死亡率6.60/100人年。HIV/AIDS患者最长的生存时间为21.38年,平均生存时间13.67年(95%CI:12.67~14.66),中位生存时间为14.79年。1年生存率为88%,5年生存率为77%,10年生存率为61%。Cox比例风险模型分析显示,40~49岁年龄组、文盲、未接受高效抗病毒治疗、CD4+T细胞计数〈200个/mm3的研究对象的全死因死亡率要分别高于15~39岁年龄组、高中或中专/大专及以上文化程度、接受抗病毒治疗和CD4+T细胞计数≥200个/mm3。结论近年来,福建省HIV/AIDS患者全死因死亡率呈逐年下降趋势,可针对生存时间的影响因素进行持续有效的干预,扩大关怀服务的覆盖范围,以进一步改善HIV/AIDS患者的生存质量,减少死亡。 Objective To discuss the survival time and related factors among HIV/AIDS patients (HIV/ AIDS) in FuJian province. Methods Newly reported HIV/AIDS patients in Fujian province were recruited into cohort study between January 1, 1987 and December 31, 2014. Information related to the death of HIV/ AIDS patients was collected and death and survival rates were calculated. Univariate and multivariate analysis were used to analyze the influencing factors of survival time. Results A total of 5 163 HIV/AIDS patients were recruited and 849 deaths were reported with the mortality rate of 6.60 per 100 person per year. The aver- age survival time of HIV/AIDS patients was 13.67 years with the longest of 21.38 years (95~C1: 12.67~ 14.66) and the median of 14.79 years. The cumulative survival rates of 1, 5 and 10 year were 88~, 77~ and 61 ~/6o, respectively. Analysis of cox proportional hazard model indicated that the death rates of patients aged 40 to 49 years, with low education, not receiving highly effective anti-retroviral therapy, and CD4 T cell counts less than 200/mm3 were higher than those of 15 to 39 years old, with higher education background, having re- ceived highly effective anti-retroviral therapy, and CD4+ T cell counts greater than or equal to 200/ram3. Conclusions The all-cause mortality rate of HIV/AIDS patients keeps going down in recent years, it is neces- sary to implement the effective interventions continuously based on the factors related to the mortality of HIV/ AIDS patients, expand the coverage of patients care and further improve the life quality of HIV/AIDS patients.
出处 《中国预防医学杂志》 CAS 2016年第2期134-138,共5页 Chinese Preventive Medicine
关键词 人类免疫缺陷病毒 获得性免疫缺陷综合征 死亡率 生存时间 COX回归分析 Human immunodeficiency virus Acquired immune deficiency syndrome Mortality rate Survivaltime Cox regression analysis
  • 相关文献

参考文献11

  • 1Gottlieb MS, Schroff R, Schanker HM, et al. Pneumocystis carinii pneumonia and mucusal eandidiasis in previously healthy homosexual men: evidence of a new acquired cellu lar immunodeficiency[J]. N Eng J Med, 1981, 305 (24) : 1425-1431.
  • 2Barre-Sinoussi F, Chermann JC, Rey F, et al. Isolation of a T-lymphotropic retrovirus from a patient at risk for acquired immune deficiency syndrome (AIDS)[J]. Science, 1983, 220 (4599): 868-871.
  • 3Zhang FJ, Dou ZH, Ma Y, et al. Effect of earlier initiation of antiretroviral treatment and increased treatment coverage on HIV-related mortality in China: a national observational cohort study [J]. Lancet Infect Dis, 2011, 11 (7): 516-524.
  • 4黄东升,郑维斌,杨家芳,李艳萍.1990-2012年云南省保山市HIV/AIDS病例全因死亡率及其影响因素研究[J].中国卫生统计,2014,31(3):374-378. 被引量:15
  • 5马功燕,马泰,黄健,程婷婷,陈进,陈海燕.安徽省六安市艾滋病病毒感染者及患者生存状况及相关因素分析[J].疾病监测,2014,29(9):716-720. 被引量:4
  • 6Chihana M, Floyd S, Molesworth A, et al. Adult mortality and probable cause of death in rural northern Malawi in the era of HIV treatment [J].Trop Med Int Health, 2012, 17 (8): e74-e83.
  • 7Stewart A, Chan CS, To K, etal. Causes of death in HIV patients and the evolution of an AIDS hospice: 1988-2008 [J].AIDSResTreat, 2012= 390-406.
  • 8Chkhartishvili N, Sharvadze L, Chokoshvili O, et al. Mortality and causes of death among HIV-Infected individuals in the country of georgia.- 1989 2012 [J]. AIDS Res Hmn Ret- roviruses, 2014, 30 (6): 560-566.
  • 9Paeheco YM, Jarrin I, Delamo J, et al. Risk factors, CD4 long term evolution and mortality of HIV infected patienls who persistently maintain low CD4 counts, despite virologi calresponsetoHAART[J].CurrHIVRes, 2009, 7 (6): 612-619.
  • 10Prince PD, Matser A, van Tienen C, et al. Mortality rates in people dually infected with HIV-1/2 and those infected with either HIV-1 or HIV-2: a systematic review and mesa analysis [J]. AIDS, 2014, 28 (4): 549-558.

二级参考文献21

  • 1张福杰,文毅,于兰,马烨,潘捷,赵燕.艾滋病的抗病毒治疗与我国的免费治疗现状[J].科技导报,2005,23(7):24-29. 被引量:104
  • 2Li TS. Antiretroviral therapy in China:success and challenge. Natl Med J China,2009,89( 13 ) :865-866.
  • 3Reynolds NR. Adherence to antiretroviral therapies : state of the science. Curr HIV Res,2004,2 (3) :207-214.
  • 4WHO, UNAIDS, and UNICEF. Global HIV/AIDS response : epidemic update and health sector progress towards universal access:progress report. The World Health Organization, Geneva, Switzerland ,2011.
  • 5Zhang FJ,Dou ZH, Ma Y, et al. Effect of earlier initiation of antiretrovi- ral treatment and increased treatment coverage on H1V-related mortality in China:a national observational cohort study. The Lancet Infect Dis, 2011,11 (7) :516-524.
  • 6http://yn.yunnan.cn/html/2010-11/27/content_1425359.htm.
  • 7Brady MT, Oleske JM, Williams PL, et al. Declines in mortality rates and changes in causes of death in HIV-1-infected children during the HAART era. J Acquit Immune Defic Syndr,2010,53( 1 ) :86-94.
  • 8"Guidelines for the Use of Antiretroviral Agents in HIV-l-lnfected A- dults and Adolescents". AIDS info,27 Mar,2012 ,http://aidsinfo. nih. gov/guidelines/html.
  • 9Beyrer C, Razak MH, Labrique A, et al. Assessing the magnitude of the HIV/AIDS epidemic in Burma. J Acquir Immune Defic Syndr. 2003,32 (3) :311-317.
  • 10李雪华,许奕华,聂绍发,向浩,王重建.The Effect Evaluation of Highly Active Antiretroviral Therapy to Patients with AIDS in Hubei Province of China[J].Journal of Huazhong University of Science and Technology(Medical Sciences),2009,29(5):580-584. 被引量:5

共引文献16

同被引文献53

引证文献8

二级引证文献69

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部